Biotech ETF SBIO Can Get Its Groove Back
With rising Treasury yields and the Federal Reserve’s recent interest rate hike ranking as the likely culprits, the previously hot ALPS Medical Breakthroughs ETF (SBIO) is in the midst of a correction. That pullback, though, may be a buying opportunity. Despite the recent rough patch, SBIO is still up about 14% year-to-date. A case can [...]
The post Biotech ETF SBIO Can Get Its Groove Back appeared first on ETF Trends .